I am a medical oncologist specializing in the care of patients with thoracic malignancies. After completing my residency in internal medicine at the Brigham and Women’s Hospital and fellowship in medical oncology at the Dana-Farber/Partners Cancer Care program, I joined the faculty at Harvard Medical School and Massachusetts General Hospital Cancer Center.
The primary focus of my research is to develop novel therapeutic and biomarker strategies for patients with advanced lung cancers. As a clinical investigator, I am actively involved in the design and conduct of clinical trials evaluating novel targeted therapies and combination immunotherapies. My translational research efforts are dedicated to the study of resistance mechanisms and exceptional responses to targeted therapies in molecularly defined subsets of lung cancer. With my commitment to research, I hope to improve the lives of our patients with advanced lung cancers.